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Intensive Care of a Weil’s Disease With Multiorgan Failure
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Abstract
Leptospirosis is a commonly encountered type of zoonosis, espe-
cially in tropical regions. There is insufficient data regarding its fre-
quency in non-tropical regions such as Turkey. Although leptospi-
rosis presents with a mild icteric form in nearly 90% of cases, it can 
lead to Weil’s disease characterized by fever as well as fulminant 
hepatorenal and respiratory failure, in approximately 5 - 10% of 
cases. In this case report, we present a patient with Weil’s disease, 
complicated with multiorgan failure.
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Introduction
Leptospirosis is a re-emerging spirochetal zoonosis with a 
worldwide distribution affecting both animals and humans. 
The incidence of Leptospirosis is significantly high in re-
gions with a warmer climate as compared to those with a 
temperate climate. The data regarding its frequency in non-
tropical regions, such as Turkey, are insufficient [1]. Human 
infection results from exposure to infected urine of carrier 
mammals,  either  directly  or  via  contamination  of  soil  or 
water. The clinical syndromes may vary from a subclinical 
infection to a severe illness. The disease usually presents as 
a flu-like illness with mild hepatic and renal impairment. Se-
vere forms of leptospirosis are characterized by severe hepa-
torenal dysfunction, mental status changes and haemorrhagic 
diathesis, but rarely with multiorgan dysfunction. Although 
it may potentially have a fulminant and fatal course, lepto-
spirosis usually remains as an underdiagnosed cause of mul-
tiorgan failure. Pulmonary involvement is not uncommon 
(20 - 70%), but symptoms are usually mild without sequelae. 
Acute respiratory distress syndrome (ARDS) requiring arti-
ficial ventilation is very rare and has a high mortality rate of 
up to 50%, often associated with pulmonary haemorrhage 
due to endothelial damage.
Although leptospirosis presents with a mild icteric form 
in nearly 90% of cases, it can lead to Weil’s disease charac-
terized by fever as well as fulminant hepatorenal and respi-
ratory failure in approximately 5 - 10% of cases. Weil’s dis-
ease may potentially have a fulminant and fatal course and, 
therefore, requires critical care. Diagnosis based on clinical 
assessment alone may not always be accurate, yet the exact 
diagnosis may only be established upon clinical suspicion. 
The establishment of the diagnosis requires the presence of 
clinical  symptomatology  together  with  the  demonstration 
of leptospirosis in blood or urine cultures, or on serological 
testing. The prompt initiation of antibiotherapy is key to dis-
ease control as well as the prevention of the urinary spread 
of the microorganism [2]. 
 
Case Report
A 24-year-old male was admitted to the Department of In-
fectious Disease of the State Hospital with fever, lethargy, 
muscle  pain,  headache,  productive  cough,  and  decreased 
appetite. Upon evaluation he was put on ceftriaxon sodium, 
2 g/day with suspicion diagnosis of meningitis. He was re-
ferred to Emergency Department of the University Hospi-
tal in the same province two days after admission since he 
failed to improve clinically despite an antibiotherapy. He 
lived on his own, smoked one and a half packs of cigar per 
day, and worked for the sewerage company. He had no sig-
nificant past medical or surgical history and had not recently 
travelled outside the city. On admission, he was apathic and 
stuporous. Initial examination revealed neck stiffness and 
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Table 1. Laboratory Findings During Management of Case
 
First (Initial)
 
Second (Ten Days After)
 
Third (Before Discharge)
Leukocyte (/mm3) 37000 26900 7800
Hemoglobin (g/dl) 17.9 9.9 15
Hematocrit (%) 51 28.9 35
Platelet (/mm3) 36000 56000 206000
CRP (g/dl) 107 17.1 10.4
Glucose 43 110 135
LDH (U/L) 29
ALP U/L 158
Urea (mg/dl) 45 100 14
Creatinine (mg/dl) 4.18 4 1
AST (U/L) > 4202 U/L 1041 37
ALT (U/L) > 4113 U/L 1050 67
GGT(U/L) 82 30.5
Albumin 4 3.5
Sodium (mEq/lt) 142 145 143
Potassium (mEq/lt) 4.2 5.7 4
Total bilurubin (mg/dl) 4.3 1.5
Direct biluribin (mg/dl) 2.1 0.5
Protrombin time sec 26.7
aPTT sec (24 - 36) 6.89
Pt 16%
Fibrinogen mg/dl 62.8 200
D-Dimer mikrogFE U/ml 1.36
INR 2.48 1.17 1.1
Sedimentation 45 2
AntiHBsAg IU/ml (micro) 19.5
Anti-HCV Negative
pH 7.386 7.35
pCO2 mmHg 30 45
pO2 mmHg 63 96
Saturation (%) 92.2 98
BE -5.6 3
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jaundice. His body temperature was 36.0○C, heart rate 122 
beats/min,  arterial  blood  pressure  90/60  mm  Hg,  respira-
tory rate 19/min and oxygen saturation 96% while breathing 
room air. On auscultation, his heart sounds were normal and 
air entry was equal on both lungs with occasional scattered 
wheezing. Initial laboratory investigations showed in Table 
1. ECG showed sinus tachycardia and chest X-ray revealed 
mildly increased bronchoalveolar markings. An initial diag-
nosis of sepsis resulting from a lower respiratory tract in-
fection, Weil’s disease, acute hepatitis, and acute renal im-
pairment was made and he was transferred to a critical care 
ward. Within a few hours, his condition deteriorated. He was 
breathless, hypoxic, and hypotensive (arterial pressure 80/40 
mmHg) despite the infusion of colloids and crystalloids. He 
became exhausted, deeply hypoxic, and acidotic (blood gas, 
FIO2 0.9, pH 7.34, PaCO2 4.8 kPa, base excess 26.4 mmol 
litre-1, bicarbonate 19.4 mmol litre-1, PaO2 7.7 kPa, SaO2 
84%). Noradrenaline infusion was started to maintain a mean 
arterial pressure (MAP) of more than 70 mm Hg. Since his 
condition continued to rapidly deteriorate, the decision was 
made for tracheal intubation. Bilevel continuous positive air-
way pressure (BiPAP) and invasive monitoring was initiated. 
Investigations  repeated.  Repeat  investigation  revealed  an 
extensive bilateral alveolar shadowing, stimulating ARDS 
as well as worsening of renal and hepatic function. Repeat 
laboratory  investigations  showed  in  Table  1.  Abdominal 
ultrasound revealed no abnormalities, and a cardiac echo 
showed normal right and left ventricular function. With the 
background history of working for the sewerage company, 
along with hepatic and renal impairment, leptospirosis was 
suspected and appropriate samples were obtained and sent 
to the reference laboratory. Samples were also forward for 
atypical screening. Treatment was initiated with amoxicillin-
sulbactam and meropenem, and later changed to teicoplanin 
and netilmycin, followed by tigecycline. Platelets, packs of 
erytrocytes and packs of fresh frozen plasma were trans-
fused. Pressure control ventilation (PEEP 10 cmH2O, peak 
airway pressure 27 cmH2O, FIO2 0.9) was instituted, main-
taining a PaO2 of 90 mm Hg. High-dose noradrenaline (0.8 
mgm kg-1 min-1) was required to maintain a MAP of 70 mm 
Hg. He had clinically adequate filling pressure and was start-
ed on a diuretic infusion, to which he responded well. There 
was significant pulmonary bleeding for the first 4 days and 
his platelets were low. He required sedation, and ventilatory 
support with lung protection strategy for 7 days before seda-
tion and noradrenaline could be weaned off. Chest X-rays 
were compatible with ARDS and started to improve after one 
week. A percutaneous tracheostomy was performed on 10th 
day, using the method of Griggs. He required intermittent 
hemodialysis for 20 days, to be followed by bedside renal 
replacement therapy with hemodiafiltration (Prisma®). Later 
on he was weaned slowly after 10 days and was discharged 
to a medical ward on day 36. C-reactive Protein was down to 
17.1. Although the initial testing for leptospirosis was nega-
tive, a second specimen was sent after 30 days, which re-
sulted also negative for leptospirosis. 
Discussion
  
Leptospirosis  has  a  wide  clinical  spectrum  ranging  from 
asymptomatic  cases  to  severe  Weil’s  disease.  Pathogenic 
mechanisms of leptospirosis may be divided into direct ef-
fects by Leptospira and host immune response to infection. 
One mechanism of virulence is motility and the ability of 
Leptospira to swim through viscous media. Motility is prob-
ably more important in initial infection and in dissemination 
of organisms from the site of entry to sites of end-organ dam-
age such as lung, liver, kidney, eye, and brain. Severe forms 
show multiorgan involvement such as liver, kidney and lung. 
Diagnosis of leptospirosis can also be defined in accordance 
with WHO recommendations [3], where a diagnostic ‘score’ 
is obtained, based on six clinical criteria, two laboratory-
determined criteria and an epidemiological criterion. Lep-
tospirosis is suspected when the score is 20, with a strong 
presumption when the score is 24. Prognostic factors associ-
ated with mortality have only been evaluated in a few stud-
ies. In a Polynesian hospital, 71 severe cases of leptospirosis 
were studied retrospectively during a period of 2 years. All 
71 patients were admitted to the intensive care unit. On mul-
tivariate analysis, three independent variables were found to 
be associated significantly with severity, namely oliguria, 
hypotension and abnormal chest auscultation (the presence 
of crackles or rhonchi). These symptoms are consistent with 
those reported in other series [4]. The mortality rate of 7% 
was within the range of 4 - 10% reported in studies from 
France and the USA [5, 6]. Differences in the mortality rate 
can be attributed to the criteria chosen for patient inclusion 
and to the severity of the disease. 
In  the  presence  of  leptospirosis,  survival  depends  on 
rapid diagnosis as well as early and appropriate manage-
ment. The mortality rate for oliguric patients with acute renal 
failure is higher than that for patients with persistent diuresis 
[7, 8] 
The incidence of pulmonary involvement in leptospi-
rosis varies between 17% and 70%. It was shown that the 
mortality rate rose from 4.8% to 11% when patients devel-
oped respiratory symptoms and ARDS. Cardiac involvement 
is probably more common than that reported [9]. With the 
background history of working for the sewerage company 
along with hepatic and renal failure, laboratory investiga-
tions  revealed  multiorgan  failure  in  the  patient  presented 
hereby. He had disseminated intravascular coagulation and 
bleeding from multiple sites. He required intermittent hemo-
dialysis for 20 days, followed by bedside renal replacement 
therapy with hemodiafiltration (Prisma®). He was weaned 
slowly and discharged to a medical ward on 36th day. He-
patic function and coagulation parameters normalized in 10 
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days, urea and creatinine levels remained high until 20 days 
of admission. 
Functional or structural hepatic damage has been known 
to follow systemic infections, in one of two scenarios. In the 
first scenario, the infection primarily involves the liver, as 
is the case in spirochete, rickettsia, viral and myocobacte-
rial infections. In the second scenario, intrahepatic cholesta-
sis is observed in the absence of hepatic involvement [10]. 
Various factors can contribute to renal impairment in Weil’s 
disease. These include hypovolemia, endotoxin-associated 
vasoconstriction, ischemia and acute tubular necrosis. Renal 
involvement is a major cause of mortality. The Leptospiras 
are found in the renal parenchyma and the tubular lumen 
[11]. In our case, the diagnosis of leptospirosis could be 
verified neither in cultures and serological testin nor using 
dark field microscopy. The background history and clinical 
progress was deemed adequate to establish the diagnosis 
and, therefore, appropriate antibiotics covering leptospirosis 
were initiated. 
Leptospires are sensitive to most antimicrobial agents 
in vitro, but the importance of the in-vitro sensitivity testing 
on clinical outcome for these agents has not been assessed 
in clinical trials. A recent report shows that while Lepto-
spira are sensitive in vitro to several antimicrobial classes, 
some variability was reported in the in-vitro susceptibility 
of various Leptospira species to a range of newer (ampi-
cillin-sulbactam,  cefotaxime,  ceftriaxone,  azithromycin, 
telithromycin, ciprofloxacin, moxifloxacin) and older anti-
microbials (penicillin, ampicillin, amoxicillin, doxycycline, 
tetracycline, chloramphenicol, erythromycin). Many of the 
Leptospira species tested were more sensitive to ampicillin/
sulbactam than to ampicillin alone [2]. Due to the observa-
tion of hospital infections caused by agents such as pseudo-
monas auroginosa, acinetobacter baumannii, candida albi-
cans, that are among usual suspects in the setting of ICU and 
that are grown in serial cultures, treatment with antibiotics is 
continued in accordance with sensitivity testing. Impatient 
with the severe form of leptospirosis, clinical improvement 
has been reported to take two to four weeks. Pulmonary 
complications, massive bleeding in particular, are the cause 
of death in 20 to 70% of cases with leptospirosis [12]. In a 
study reporting on autopsy findings for 62 cases of leptospi-
rosis in India, young males presenting with fever, dyspnea, 
hemoptysis, bleeding, oliguria and jaundice were observed 
to die immediately following their hospital admissions. Nad 
massive interalveolar hemorrhage (48 cases), acute intersti-
tial nephritis or acute tubular necrosis (45 cases), and myo-
carditis (24 cases) were observed postmortem to support the 
serological diagnosis of leptospirosis. Wide spread bleeding 
was  observed in the heart, gastrointestinal system, brain, 
pancreas and adrenal gland, yet the cause of death was pul-
monary hemorrhage [13]. In our case, fresh frozen plasma as 
well as thrombocyte and erythrocyte suspensions were ad-
ministered due to the presence of repeated hemorrhage from 
gastrointestinal system and lungs. 
The presence of multiorgan failure necessitates the ad-
ministration of appropriate antibiotherapy, circulatory and 
respiratory support, hemodialisis, hemodiafiltration, and re-
placement of blood product. In our patient, the reversal of 
multiorgan failure was observed by 20 days despite prompt 
administration  of  antibiotics  and  hemodialisis.  Prolonged 
tracheal intubation required a tracheotomy although recov-
ery was accelerated following the tracheotomy. Pulmonary 
complications have been reported to recover in the absence 
of sequlae under respiratory support [12]. In our case, the 
administration of antibiotic therapy, early supportive care, 
enteral nutrition and intensive blood replacement provided 
clinical improvement and the patient recovered completely. 
This case is reported in attempt to remind clinicians to con-
sider leptospirosis in the evaluation of a patient with sepsis 
who develops multiple organ dysfunctions. Appropriate an-
timicrobial therapy can be life-saving. 
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